Home » Clinical Trials » Leukemia » NCT06118788
NCT06118788

A Single-arm, Dose-escalation and Dose-expansion Phase I Clinical Study to Evaluate the Tolerability, Safety and Preliminary Efficacy of BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Study Summary

This is a single-arm, single-dose dose-escalation and dose-expansion study.

Want to learn more about this trial?

Request More Info

Interventions

BG1805BIOLOGICAL
A single infusion of BG1805 Injection administered intravenously.

Study Locations

FacilityCityStateCountry
ZhuJiang Hospital of Southern Medical UniversityGuangzhouGuangdongChina
Nanfang Hospital of Southern Medical UniversityGuangzhouGuangdongChina
The First Affiliated Hospital, Zhejiang University School of MedicineHangzhouZhejiangChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026